Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells

被引:37
作者
Kollar, Peter [1 ]
Zavalova, Veronika [1 ]
Hosek, Jan [2 ]
Havelka, Pavel [3 ]
Sopuch, Tomas [4 ]
Karpisek, Michal [1 ]
Tretinova, Dominika [1 ]
Suchy, Pavel, Jr. [1 ]
机构
[1] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, CZ-61242 Brno, Czech Republic
[2] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Nat Drugs, CZ-61242 Brno, Czech Republic
[3] VUOS AS, CZ-53354 Rybitvi, Czech Republic
[4] Synthesia AS, CZ-53217 Pardubice, Czech Republic
关键词
Cellulose; Inflammation; Tumor necrosis factor; Macrophages; THP-1; cells; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; TRISTETRAPROLIN; DISEASE; PMN;
D O I
10.1016/j.intimp.2011.02.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The cytotoxicity and in vitro effects of six variously modified types of cellulose (OC - oxidized cellulose, NaOC - oxidized cellulose sodium salt, DAC - dialdehyde cellulose, CMC - carboxymethyl cellulose, MFC - microfibrilated cellulose, and MCC - microcrystalline cellulose) on the inflammatory response in macrophage-like THP-1 cells were examined, with special focus on their ability to influence gene expression and the production of TNF-alpha. The study provides evidence that DAC exerts a marked effect on the induction of TNF-alpha gene expression and its subsequent production in human macrophages. Thus, the use of DAC for anti-hemorrhagic or wound-healing therapy should be considered carefully with regard to its pro-inflammatory activity. On the contrary, MCC showed significant anti-inflammatory effects in the LPS-induced conditions, which might be beneficial for the treatment of non-healing chronic wounds, e.g., diabetic or venous ulcers. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:997 / 1001
页数:5
相关论文
共 21 条
[1]   Biologic therapy for inflammatory bowel disease [J].
Ardizzone, S ;
Porro, GB .
DRUGS, 2005, 65 (16) :2253-2286
[2]  
BELOZERSKAYA GG, 2006, PHARM CHEM J, V40, P353
[3]   Analysis of the function, expression, and subcellular distribution of human tristetraprolin [J].
Brooks, SA ;
Connolly, JE ;
Diegel, RJ ;
Fava, RA ;
Rigby, WFC .
ARTHRITIS AND RHEUMATISM, 2002, 46 (05) :1362-1370
[4]  
Buck M, 1996, AM J PATHOL, V149, P195
[5]   Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin [J].
Carballo, E ;
Lai, WS ;
Blackshear, PJ .
SCIENCE, 1998, 281 (5379) :1001-1005
[6]   Regulation of P-selectin expression by inflammatory mediators in canine jugular endothelial cells [J].
Dore, M ;
Sirois, J .
VETERINARY PATHOLOGY, 1996, 33 (06) :662-671
[7]   Transcriptional and post-transcriptional regulation of GM-CSF-induced IL-1 beta gene expression in PMN [J].
Fernandez, MC ;
Walters, J ;
Marucha, P .
JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 59 (04) :598-603
[8]  
Glaros T, 2009, FRONT BIOSCI-LANDMRK, V14, P3988, DOI [10.2735/3506, 10.2741/3506]
[9]   Synergy in cytokine and chemokine networks amplifies the inflammatory response [J].
Gouwy, M ;
Struyf, S ;
Proost, P ;
Van Damme, J .
CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (06) :561-580
[10]   Diabetes-enhanced inflammation and apoptosis - Impact on periodontal pathology [J].
Graves, DT ;
Liu, R ;
Alikhani, M ;
Al-Mashat, H ;
Trackman, PC .
JOURNAL OF DENTAL RESEARCH, 2006, 85 (01) :15-21